Browse > Article
http://dx.doi.org/10.5808/GI.2015.13.2.26

A Novel Type of Non-coding RNA, nc886, Implicated in Tumor Sensing and Suppression  

Lee, Yong Sun (Department of Biochemistry & Molecular Biology, University of Texas Medical Branch)
Publication Information
Genomics & Informatics / v.13, no.2, 2015 , pp. 26-30 More about this Journal
Abstract
nc886 (=vtRNA2-1, pre-miR-886, or CBL3) is a newly identified non-coding RNA (ncRNA) that represses the activity of protein kinase R (PKR). nc886 is transcribed by RNA polymerase III (Pol III) and is intriguingly the first case of a Pol III gene whose expression is silenced by CpG DNA hypermethylation in several types of cancer. PKR is a sensor protein that recognizes evading viruses and induces apoptosis to eliminate infected cells. Like viral infection, nc886 silencing activates PKR and induces apoptosis. Thus, the significance of the nc886:PKR pathway in cancer is to sense and eliminate pre-malignant cells, which is analogous to PKR's role in cellular innate immunity. Beyond this tumor sensing role, nc886 plays a putative tumor suppressor role as supported by experimental evidence. Collectively, nc886 provides a novel example how epigenetic silencing of a ncRNA contributes to tumorigenesis by controlling the activity of its protein ligand.
Keywords
nc886; non-coding RNA; PKR; tumor suppressor; tumor surveillance;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Mattick JS, Makunin IV. Non-coding RNA. Hum Mol Genet 2006;15 Spec No 1:R17-R29.   DOI
2 Fatica A, Bozzoni I. Long non-coding RNAs: new players in cell differentiation and development. Nat Rev Genet 2014;15:7-21.   DOI
3 Filipowicz W, Bhattacharyya SN, Sonenberg N. Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? Nat Rev Genet 2008;9:102-114.   DOI
4 Kunkeaw N, Jeon SH, Lee K, Johnson BH, Tanasanvimon S, Javle M, et al. Cell death/proliferation roles for nc886, a non-coding RNA, in the protein kinase R pathway in cholangiocarcinoma. Oncogene 2013;32:3722-3731.   DOI
5 Lee K, Kunkeaw N, Jeon SH, Lee I, Johnson BH, Kang GY, et al. Precursor miR-886, a novel noncoding RNA repressed in cancer, associates with PKR and modulates its activity. RNA 2011;17:1076-1089.   DOI
6 Stadler PF, Chen JJ, Hackermuller J, Hoffmann S, Horn F, Khaitovich P, et al. Evolution of vault RNAs. Mol Biol Evol 2009;26:1975-1991.   DOI
7 Berger W, Steiner E, Grusch M, Elbling L, Micksche M. Vaults and the major vault protein: novel roles in signal pathway regulation and immunity. Cell Mol Life Sci 2009;66:43-61.   DOI
8 Lee HS, Lee K, Jang HJ, Lee GK, Park JL, Kim SY, et al. Epigenetic silencing of the non-coding RNA nc886 provokes oncogenes during human esophageal tumorigenesis. Oncotarget 2014;5:3472-3481.   DOI
9 Lee KS, Park JL, Lee K, Richardson LE, Johnson BH, Lee HS, et al. nc886, a non-coding RNA of anti-proliferative role, is suppressed by CpG DNA methylation in human gastric cancer. Oncotarget 2014;5:3944-3955.   DOI
10 Jeon SH, Lee K, Lee KS, Kunkeaw N, Johnson BH, Holthauzen LM, et al. Characterization of the direct physical interaction of nc886, a cellular non-coding RNA, and PKR. FEBS Lett 2012;586:3477-3484.   DOI
11 Yang JH, Shao P, Zhou H, Chen YQ, Qu LH. deepBase: a database for deeply annotating and mining deep sequencing data. Nucleic Acids Res 2010;38:D123-D130.   DOI
12 Mrazek J, Kreutmayer SB, Grasser FA, Polacek N, Huttenhofer A. Subtractive hybridization identifies novel differentially expressed ncRNA species in EBV-infected human B cells. Nucleic Acids Res 2007;35:e73.   DOI
13 Nandy C, Mrazek J, Stoiber H, Grasser FA, Huttenhofer A, Polacek N. Epstein-barr virus-induced expression of a novel human vault RNA. J Mol Biol 2009;388:776-784.   DOI
14 Landgraf P, Rusu M, Sheridan R, Sewer A, Iovino N, Aravin A, et al. A mammalian microRNA expression atlas based on small RNA library sequencing. Cell 2007;129:1401-1414.   DOI
15 Oler AJ, Alla RK, Roberts DN, Wong A, Hollenhorst PC, Chandler KJ, et al. Human RNA polymerase III transcriptomes and relationships to Pol II promoter chromatin and enhancer- binding factors. Nat Struct Mol Biol 2010;17:620-628.   DOI
16 Canella D, Praz V, Reina JH, Cousin P, Hernandez N. Defining the RNA polymerase III transcriptome: genome-wide localization of the RNA polymerase III transcription machinery in human cells. Genome Res 2010;20:710-721.   DOI
17 Moqtaderi Z, Wang J, Raha D, White RJ, Snyder M, Weng Z, et al. Genomic binding profiles of functionally distinct RNA polymerase III transcription complexes in human cells. Nat Struct Mol Biol 2010;17:635-640.   DOI
18 Marshall L, White RJ. Non-coding RNA production by RNA polymerase III is implicated in cancer. Nat Rev Cancer 2008;8:911-914.   DOI
19 Treppendahl MB, Qiu X, Sogaard A, Yang X, Nandrup-Bus C, Hother C, et al. Allelic methylation levels of the noncoding VTRNA2-1 located on chromosome 5q31.1 predict outcome in AML. Blood 2012;119:206-216.   DOI
20 Cao J, Song Y, Bi N, Shen J, Liu W, Fan J, et al. DNA methylation- mediated repression of miR-886-3p predicts poor outcome of human small cell lung cancer. Cancer Res 2013;73:3326-3335.   DOI
21 Klose RJ, Bird AP. Genomic DNA methylation: the mark and its mediators. Trends Biochem Sci 2006;31:89-97.   DOI
22 Ong CT, Corces VG. CTCF: an architectural protein bridging genome topology and function. Nat Rev Genet 2014;15:234-246.   DOI
23 Garcia MA, Meurs EF, Esteban M. The dsRNA protein kinase PKR: virus and cell control. Biochimie 2007;89:799-811.   DOI
24 Marchal JA, Lopez GJ, Peran M, Comino A, Delgado JR, García-García JA, et al. The impact of PKR activation: from neurodegeneration to cancer. FASEB J 2014;28:1965-1974.   DOI
25 Jeon SH, Johnson BH, Lee YS. A tumor surveillance model: a non-coding RNA senses neoplastic cells and its protein partner signals cell death. Int J Mol Sci 2012;13:13134-13139.   DOI
26 Bi N, Cao J, Song Y, Shen J, Liu W, Fan J, et al. A microRNA signature predicts survival in early stage small-cell lung cancer treated with surgery and adjuvant chemotherapy. PLoS One 2014;9:e91388.   DOI
27 Gao W, Shen H, Liu L, Xu J, Xu J, Shu Y. MiR-21 overexpression in human primary squamous cell lung carcinoma is associated with poor patient prognosis. J Cancer Res Clin Oncol 2011;137:557-566.   DOI
28 Ransone LJ, Verma IM. Nuclear proto-oncogenes fos and jun. Annu Rev Cell Biol 1990;6:539-557.   DOI
29 Dettmer MS, Perren A, Moch H, Komminoth P, Nikiforov YE, Nikiforova MN. MicroRNA profile of poorly differentiated thyroid carcinomas: new diagnostic and prognostic insights. J Mol Endocrinol 2014;52:181-189.   DOI
30 Tahiri A, Leivonen SK, Luders T, Steinfeld I, Ragle Aure M, Geisler J, et al. Deregulation of cancer-related miRNAs is a common event in both benign and malignant human breast tumors. Carcinogenesis 2014;35:76-85.   DOI
31 Cole MD. The myc oncogene: its role in transformation and differentiation. Annu Rev Genet 1986;20:361-384.   DOI
32 Eychene A, Rocques N, Pouponnot C. A new MAFia in cancer. Nat Rev Cancer 2008;8:683-693.   DOI
33 Lasorella A, Uo T, Iavarone A. Id proteins at the cross-road of development and cancer. Oncogene 2001;20:8326-8333.   DOI